Goodbody Health : Interim Financial Report

GOODBODY HEALTH INC.

(Formerly SATIVA WELLNESS GROUP INC. )

Unaudited Condensed Interim Consolidated Financial Statements for

the three month period ended March 31, 2022

(Expressed in GBP)

NOTICE OF NO AUDITOR REVIEW

OF THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Under National Instrument 51-102 "Continuous Disclosure Obligations", if an auditor has not performed a review of the interim financial statements, the financial statements must be accompanied by a notice indicating that they have not been reviewed by an auditor.

The accompanying unaudited interim condensed consolidated financial statements of the Company have been prepared by and are the responsibility of the Company's management.

The Company's independent auditor has not performed a review of these unaudited interim condensed consolidated financial statements in accordance with standards established by CPA (Chartered Professional Accountants) Canada for a review of unaudited interim condensed consolidated financial statements by an entity's auditor.

May 24, 2022

GOODBODY HEALTH INC. (FORMALLY SATIVA WELLNESS GROUP INC.) Condensed Unaudited Interim Consolidated Statements of Financial Position (Expressed in GBP)

	Note	March 31, 2022	December 31,
			2021
		£	£
Assets
Cash and cash equivalents	5	5,937,933	6,068,172
Trade receivables		304,887	277,810
Refundable sales taxes receivable		41,499	144,597
Inventories	6	587,723	588,717
Assets held for sale	9	46,269	46,345
Prepaid expenses and deposits		434,261	146,145
Other current assets		25,052	24,372
Total Current Assets		7,377,624	7,296,158
Plant and equipment	7	2,589,515	2,602,306
Right of use assets	8	295,072	341,792
Intangible assets	10	30,133	30,941
Goodwill	10	572,072	572,072
Total Assets		10,864,416	10,843,269
Liabilities
Accounts payable and accrued liabilities		2,514,081	2,319,768
Current portion of lease obligation	11	139,158	152,111
Corporation tax provision		348,222	267,376
Other current liabilities		527,403	850,715
		3,528,864	3,589,970
Long-term portion of lease obligation	11	152,495	184,842
Total Liabilities		3,681,359	3,774,812
Shareholders' Equity	12
Share capital		15,124,402	15,124,402
Share based payment reserve		3,597,901	3,584,962
Accumulated other comprehensive Income		700,016	332,321
Deficit		(12,239,262)	(11,973,228)
Shareholders' Equity		7,183,057	7,068,457
Total Liabilities and Shareholders' Equity		10,864,416	10,843,269

Nature and continuance of operations (note 1)

Subsequent events (note 19)

Approved and authorised for dissemination on behalf of the Board of Directors on May 24, 2022:

"Marc Howells"		"Anne Tew"
Marc Howells - Director		Anne Tew - Director

The accompanying notes are an integral part of these condensed unaudited interim consolidated financial statements

GOODBODY HEALTH INC.

Condensed Unaudited Interim Consolidated Statements of Loss and Comprehensive Loss (Expressed in GBP)

	Note	For the three months ended
		March 31
		2022	2021
		£	£
Revenue		5,168,662	1,376,427
Cost of sales		(2,565,145)	(669,784)
Gross profit		2,603,517	706,643
Operating Expenses
General and administrative expenses	4	(2,372,139)	(1,244,131)
Share-based payment charges	14	(12,939)	(68,909)
Depreciation and amortization		(128,389)	(244,282)
Interest income / (expense)		(2,281)	(3,691)
Fair value (loss) / gain on investments		1,004	31
Grant income		-	2,092
Other Income	2	-	199,876
Foreign currency translation on
intercompany loans		(273,961)	(411,706)
		_________	_________
Loss before income taxes		(185,188)	(1,064,077)
Income tax		(80,846)	-
		_________	_________
Net loss		(266,034)	(1,064,077)
Items that may be reclassified to profit
or loss
Currency translation adjustment		367,695	143,725
		_________	_________
Comprehensive profit/(loss) for the
year		101,661	(920,352)
Profit/(loss) per share		Pence	Pence
Basic and diluted		0.03	(0.30)
Weighted number of shares		364,962,152	302,592,941
outstanding

The accompanying notes are an integral part of these condensed unaudited interim consolidated financial statements

GOODBODY HEALTH INC.

Condensed Unaudited Interim Consolidated Statements of

Changes in Equity

(Expressed in GBP)

			Share Based
	Number of	Share Capital	payment	Trans		Total
	Outstanding		Reserve	lation Reserve	Deficit	Shareholder's
	Shares					Equity
		£	£	£	£	£
Balance, January 1, 2021	302,592,941	12,915,426	2,847,218	153,693	(9,658,848)	6,284,489
Share-based payments	-	-	68,909	-	-	68,909
Currency translation reserve	-	-	-	143,725	-	143,725
Net loss	-	-	-	-	(1,064,077)	(1,064,077)
Balance, March 31, 2021	302,592,941	12,915,426	2,943,127	297,418	(10,722,925)	5,433,046
Balance, January 1, 2022	364,962,152	15,124,402	3,584,962	332,321	(11,973,228)	7,068,457
Share-based payments (note 14)	-	-	12,939	-	-	12,939
Currency translation reserve	-	-	-	367,695	-	367,695
Net loss	-	-	-	-	(266,034)	(266,034)
Balance, March 31, 2022	364,962,152	15,124,402	3,597,901	700,016	(12,239,262)	7,183,057

The accompanying notes are an integral part of these condensed unaudited interim consolidated financial statements.